5,776 filings
6-K
GSK
GSK Plc
19 Apr 24
Director/pdmr Shareholding
10:56am
6-K
GSK
GSK Plc
17 Apr 24
Director/pdmr Shareholding
10:52am
6-K
GSK
GSK Plc
17 Apr 24
Results from Long-term Data Relating to Shingrix
6:12am
6-K
GSK
GSK Plc
17 Apr 24
GSK Announces Additional EAGLE-1 Results
6:07am
6-K
GSK
GSK Plc
16 Apr 24
Amendment - Director/pdmr Shareholding
9:49am
6-K
qildwqcgxahh0 yk
16 Apr 24
Fda Accepts GSK Meningitis Vaccine Candidate File
6:20am
6-K
ogf7ekau1zuy4xd
15 Apr 24
Director/pdmr Shareholding
11:26am
6-K/A
mhix86z
4 Apr 24
Replacement - Total Voting Rights
7:46am
6-K
33sqp18o23nlr
2 Apr 24
Total Voting Rights
1:17pm
6-K
6ce0ws00r6qkx
26 Mar 24
Director/pdmr Shareholding
7:45am
F-3ASR
r5iapz79l4 zti
25 Mar 24
Automatic shelf registration (foreign)
2:01pm
6-K
zq71x7t 7pa4b3eaph
25 Mar 24
Notice of Agm
9:38am
6-K
sb0pw
22 Mar 24
Transfer of Treasury Shares
12:48pm
6-K
0wfuvheq1n f1agi
22 Mar 24
Director/pdmr Shareholding
12:17pm
6-K
tv7o3qr tknzue43r8l6
18 Mar 24
New Phase III Jemperli Data In Endometrial Cancer
9:56am
6-K
cq56l5
13 Mar 24
Director/pdmr Shareholding
1:15pm
6-K
bgrsrwyg 41djb
8 Mar 24
Board Committee Change
12:48pm
6-K
rd27kfv19k svo
7 Mar 24
GSK Announces Positive Blenrep DREAMM-8 Results
6:13am
6-K
r0of9m 8wavdihfo8sn1
6 Mar 24
VIIV Lai VS Oral Soc Data In Adherence-challenged
11:11am
6-K
apbem4j zo
5 Mar 24
GSK Annual Report 2023 on Form 20 F
1:09pm